2. 1986
1989/90
1996 2000/01 2004
2001
2002
2003/04
1997
1998
1999
1990
1991
1992/93
1994
1986/87
1989
Funding from founding
shareholders in 1985
sees Sydney IVF
operations commence at
Macquarie Street.
Sydney IVF is operating
profitably.
Molecular DNA
technology
(DNALabs) in
use at Sydney
IVF.
PGD services established.
Joint venture with SUFW
for biochem screening of
early pregnancies.
Liverpool clinic opens.
Gosford and Port
Macquarie IVF services
open.
Sydney IVF
scientist
produces
Australia’s
first human embryonic
stem cells from second
donated embryo thawed.
Joint venture with
Newcastle IVF clinic and
IVF services at Lingard
Hospital.
Canberra clinic
opens and
Australia’s first
comprehensive
Miscarriage Management
Program starts.
Sydney IVF
blastocyst
culture and PGD
techniques receive
international attention and
we receive 4 licences for
embryo research (the1st
in Australia under new
legislation).
Sydney IVF
receives $1.6
million R&D
grant.
Licensing
agreement with
Cook medical
to manufacture
and distribute Sydney IVF
designed embryo culture
medium worldwide – by
2007 it was sold in over
50 countries.
Independent Ethics
Committee established.
Launceston, Lismore and
Tamworth clinics open.
World blastocyst biopsy
technique developed.
Sydney IVF
takes over
provision
of public
hospital IVF services at
RPA Hospital, Sydney.
Work commences to
develop a better culture
medium for worldwide
use.
First of the
regional/interstate
and overseas
clinics open
starting with Orange,
NSW and joint IVF
venture with Bangkok,
Thailand.
Sydney IVF moves to
bigger premises at
O’Connell Street.
Coffs Harbour and
Wollongong clinics open.
First transvaginal
ultrasound guided IVF
egg retrieval and GIFT
(Gamete Intrafallopian
Transfer).
Sydney IVF
doctor develops
mobile incubator
for oocytes (eggs).
Cytogenetic lab opens
(Sydney Genetics).
RPA
2004/05
2005/06
Sydney IVF launches
new brand look and feel
after almost 20 years in
business.
Produces stem cells to
pharmaceutical standards
for Singapore-based client.
Acquires majority
share in Hollywood IVF
clinic, Perth and also
establishes Superior ART
in Bangkok, Thailand.
Sydney IVF
receives $2.5
million R&D
grant.
31 years of world leading fertility
3. 2006 2010/11
2014
2014/15
2015
2015/16
2016/17
2011/12
2012/13
2013/14
2007
2007/08
2008/09
2009/10
Sydney IVF relocates
to bigger
premises
at 321
Kent Street.
Sydney IVF’s PGD
Assistance Program
launches to help couples
unable to afford the full
cost of PGD treatment.
Introduction of Next
Generation Sequencing
(NGS).
Genea signs global
Collaboration Agreement
with Merck KGaA and
establishes Global
Fertility Alliance with
Merck KGaA and Illumina.
PGD/PGS testing
relaunches as
GeneSure®
.
GeneScreen CF®
,
GeneScreen PLUS®
,
GeneSyte®
and
GeneSyte PLUS®
all
part of Genea’s genetic
testing suite.
Wollongong,
Coffs Harbour
and North
West clinics
celebrate anniversaries.
Gavi®
and Geri®
installed
into Genea clinics.
Launch of new vision
and business purpose
statements.
Genea moves into
renovated Kent Street
offices.
Genea signs major
sponsor agreement with
Netball NSW.
Grow by GeneaTM
launches.
Gidi®
, Genea-developed
identification instrument
for labs, launches.
Genea Consult launches.
Centre of Excellence for
Fertility launches.
Genea Biocells opens in
San Diego.
First human embryos
frozen in Gavi®
and
first pregnancy from an
embryo frozen in Gavi®
New monitoring
centres (pathology and
ultrasound) open.
Genea raises $30 million
in oversubscribed capital
raising.
Sydney IVF rebrands as
Genea.
Superior ART receives
Prime Minister’s Export
Award 2012.
New brands Genea
Biocells and Genea
Biomedx.
3rd generation embryo
culture medium suite
launches (Gems®
).
Launch
of Genea
pathology
collection
services in Kent
St and selected sites.
Genea Biomedx
establishes facility in UK
and media processing in
Kent Street.
Genea Biocells
announces the first robust
and scalable skeletal
muscle differentiation
process for human
pluripotent stem cells.
Receive 3rd major R&D
grant for
$2.7 million.
Prepare first single gene
affected stem cells for
research into Huntington’s
and FSHD.
North West clinic opens
at Bella Vista.
Eight out of 10 national
embryo research licences
are now held by Sydney
IVF.
Introduces world first
molecular method for
detecting unbalanced
chromosomes
translocation errors in
embryos.
Development of
automation device for
vitrification commences
(Gavi®
).
2014/15
Genea Oxford Fertility
opens.
4. A message from the CEO
Thirty-one years after the conception of Sydney
IVF, the purpose of Genea remains true to
the original principles put in place by founder
Professor Robert Jansen. Genea’s focus is on
innovation, improving fertility treatment so we
can maximise patients’ chance of having a baby.
This year, we took time to look forward and
articulate our 2020 business strategy and
company vision.
TO PIONEER SCIENCE
DELIVERED WITH HEART,
UNLOCK LIFE’S POSSIBILITIES
AND CREATE HEALTHY
FUTURES GLOBALLY.
Genea’s virtuous circle
model is key to our
ability to innovate
fertility treatment
and deliver our
vision.
Genea Fertility
provides our
Genea Biomedx
team with insights
on the needs and
challenges of patients,
doctors, nurses and
scientists. These insights
lead to new ideas, ways to improve
technology and thoughts on how to streamline
processes. As a result, laboratory innovations
are then developed and commercialised which
in turn sees improvements that are delivered to
patients globally.
Genea Biocells also forms part of the virtuous
circle, using altruistically donated embryos
from our fertility business to create stem cells
as part of our platform to lead the way in drug
discovery with contracted pharmaceutical
customers.
Every touch point of the circle helps us innovate
and revolutionise products and services,
delivering on our vision to pioneer science
responsibly and create healthy futures globally.
When articulating our 2020 plan, as part of
the process, we asked our staff to answer
two questions:
What do you like most about working at Genea?
What do you find unique about Genea’s
culture?
The following pages include some of the
120 staff responses received from across
our Australian clinics, as well as our UK and
US sites. It is evident, as you read over these
inspirational comments that without our people,
this organisation and our innovations wouldn’t
exist. Our staff are our greatest asset.
Tomas Stojanov, CEO.
5. We maximise the potential for our patients
to experience the joy of having a baby.
To be a trusted global pioneer in IVF technologies, dedicated
to the creation and advancement of standardised and
automated infertility solutions.
Our purpose is to accelerate the development of therapies for
patients with neuromuscular diseases by utilizing clinically relevant,
stem cell-based discovery platforms.
19. “I feel like I make a difference every single day
to individuals and couple but also to future
generations – the care and technology here at
Genea I know and feel very much so is the best,
and that’s something to be really proud of.”
- Fertility Nurse
24. “I think what definitely makes Genea unique is the
constant pushing of boundaries. I work with an amazing
group of really bright scientists, trying to push the best
results for our patients”
- Embryologist
27. “Genea has a real vision for research
and development, and we are very lucky to
work for a company who sees the future as
important aswell as the present”
- Principle Scientist, Biomedx
30. What do you find unique
about Genea’s culture?
31. Genea really invests in their people, we have a
program called GFY which offers gym classes,
personal training… just really great things to
encourage a really good work-life balance.”
- Patient Relationship Coordinator
32.
33. What do you find unique
about Genea’s culture?
34.
35. What do you find unique
about Genea’s culture?
36. What do you find unique
about Genea’s culture?
37.
38.
39. What do you find unique
about Genea’s culture?
40. What do you find unique
about Genea’s culture?
41.
42.
43. What do you find unique
about Genea’s culture?
44. What do you find unique
about Genea’s culture?
